Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: March 2021

MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Partners with Oracle to Offer Oracle CX Suite

Posted on March 10, 2021 by MissionIR

iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China and a member of Oracle PartnerNetwork (“OPN”) is working with Oracle to develop a powerful tailored SaaS offering that empowers companies to better serve and connect … Continue reading →

Posted in iClick Interactive Asia Group Ltd. ICLK, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Collaborates to Advance Commercialization of Patented UST Platform

Posted on March 10, 2021 by MissionIR

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life science and other industries, together with the College of Food, Agricultural and Environmental Sciences (“CFAES”) at Ohio State University, recently announced a strategic agreement for … Continue reading →

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Leverages ‘Absolute Powerhouse Compound’ as IND Status Paves Way for Clinical Trials

Posted on March 10, 2021 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP) CEO John Climaco, in a recent podcast, showed his excitement at news that the U.S. Food and Drug Administration (“FDA”) had granted Berubicin investigational new drug (“IND”) status. The IND designation clears the way for the … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Emerging Growth Virtual Conference

Posted on March 10, 2021 by MissionIR

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that its CEO James Sapirstein will present at the virtual Maxim Group Emerging Growth Virtual Conference. The two-day conference is slated for March 17–18, … Continue reading →

Posted in AzurRx BioPharma Inc. AZRX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) to Host Q4 and Full-Year 2020 Results Conference Call

Posted on March 10, 2021 by MissionIR

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D metal printing industry, today announced that it will hold a conference call to discuss its results for the four quarter and year ended December 31, … Continue reading →

Posted in Sigma Labs Inc. SGLB | Leave a comment

Companies Look to SRAX Inc. (NASDAQ: SRAX) to Maximize Analytics Insight Capabilities

Posted on March 10, 2021 by MissionIR

Data, not time, is now a company’s most valuable asset Investing in analytics leads to a host of benefits, including higher growth SRAX’s innovative Sequire technology unlocks stock buyers’ behaviors, trends for issuers of publicly traded companies Today, businesses need … Continue reading →

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announced Partner Has Received ISO Certification for Rapid COVID-19 Test

Posted on March 10, 2021 by MissionIR

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has announced that 3a-diagnostics GmbH (“3a”) has received EN ISO 13485 certification for its rapid point-of-care, SARS-CoV-2 RT-PCR … Continue reading →

Posted in XPhyto Therapeutics Corp. XPHYF | Leave a comment

MissionIRNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces FDA 510(k) Application for Exclusive Oral Appliance

Posted on March 10, 2021 by MissionIR

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), recently submitted an application to the U.S. Food and Drug Administration (“FDA”) for its … Continue reading →

Posted in Vivos Therapeutics Inc. VVOS | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Hits Milestone in AI Platform Development for Ovarian Cancer

Posted on March 9, 2021 by MissionIR

Cancer screenings, treatments declined during COVID-19 pandemic, highlighting need for personalized therapies to improve outcomes Comprehensive genomic, transcriptomic sequencing of patient samples complete, patient outcome data obtained from UPMC-Magee Project is template for future partnerships with other healthcare institutions to … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Upsizes Its Bought Deal Offering Due to Surge in Demand

Posted on March 9, 2021 by MissionIR

Cybin’s latest offering generated exceptional demand; announces upsize of “bought deal” offering Burgeoning psychedelic sector attracts investors’ attention as compound may prove effective in mental health treatments. Cybin appears set for rapid growth as research accelerates, public acceptance grows. Cybin … Continue reading →

Posted in Cybin Inc. CLXPF, Cybin Inc. CYBN | Leave a comment